Integrated Diagnostics Holdings Plc

  • Market Cap: N/A
  • Industry: Hospital
  • ISIN: JE00BLKGSR75
USD
0.61
0 (0.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Integrated Diagnostics Holdings Plc stock-summary
stock-summary
Integrated Diagnostics Holdings Plc
Hospital
Integrated Diagnostics Holdings plc is an integrated diagnostics services provider in Egypt. The Company operates in three geographic areas: Egypt, Sudan and Jordan. The Company provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The Company offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The Company's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The Company also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.
Company Coordinates stock-summary
Company Details
12 Castle Street , SAINT HELIER None : JE2 3RT
stock-summary
Tel: 44 1534 847000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.03%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Lord Anthony St John
Non-Executive Independent Chairman
Prof. Dr. Hend El Sherbini
Group Chief Executive Officer, Executive Director
Mr. Richard Phillips
Non-Executive Director
Mr. Hussein Choucri
Non-Executive Independent Director
Mr. James Nolan
Non-Executive Independent Director
Mr. Dan Olsson
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
33 Million
(Quarterly Results - Sep 2024)
Net Profit:
5 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 395 Million ()

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.52%

stock-summary
Debt Equity

-0.66

stock-summary
Return on Equity

38.83%

stock-summary
Price to Book

7.41